
Cradle, based in Amsterdam with an office in Zurich, offers generative-AI software that speeds up protein design and engineering.
Biotech and industrial labs use it to develop therapeutics, enzymes, vaccines and sustainable materials, replacing slow trial-and-error with model-guided suggestions. By keeping customers' data their own, it has built trust with R&D teams wary of sharing proprietary biology.
It sits at the fast-growing intersection of generative AI and the life sciences.